ADMA BIOLOGICS, INC. Business Finance Contracts & Agreements
69 Contracts & Agreements
- Credit Agreements (15 contracts)
- Exchange Agreements (9)
- Investor Rights Agreements (1)
- Loan Agreements (8)
- Note Agreements (1)
- Pledge Agreements (1)
- Purchase Agreements (5)
- Registration Rights Agreements (2)
- Release Agreements (1)
- Security Agreements (3)
- Share Agreements (1)
- Stock Agreements (6)
- Underwriting Agreements (10)
- Warrant Agreements (6)
- Amendment No. 2 to the Credit and Guaranty Agreement, dated as of May 1, 2023 (Filed With SEC on May 2, 2023)
- Form of Warrant to Purchase Common Stock (Filed With SEC on May 2, 2023)
- Amendment No. 1 to Credit Agreement and Guaranty, dated March 23, 2023 by and among the Company, Hayfin Services LLP and the lenders party thereto (Filed With SEC on March 23, 2023)
- Underwriting Agreement, by and between the Company and Raymond James & Associates, Inc., as representative of the several underwriters named therein, dated as of December 7, 2022 (Filed With SEC on December 7, 2022)
- Security Agreement, dated as of March 23, 2022, by and among the Company, certain subsidiaries of the Company and Hayfin Services LLP (Filed With SEC on March 24, 2022)
- Credit Agreement and Guaranty, dated as of March 23, 2022, by and among the Company, Hayfin Services LLP and the lenders party thereto (Filed With SEC on March 24, 2022)
- Form of Warrant to Purchase Stock, in the form issued by the Company to various entities affiliated with Hayfin Services LLP, dated as of March 23, 2022 (Filed With SEC on March 24, 2022)
- Rights Agreement, dated as of December 20, 2021, by and between ADMA Biologics, Inc. and Continental Stock Transfer and Trust Company, as rights agent (Filed With SEC on December 21, 2021)
- Underwriting Agreement, by and between the Company and Raymond James & Associates, Inc., as representative of the several underwriters named therein, dated as of October 21, 2021 (Filed With SEC on October 21, 2021)
- Second Amendment to Plasma Purchase Agreement, effective as of May 12, 2021, by and between ADMA BioManufacturing, LLC and Grifols Worldwide Operations LTD (Filed With SEC on May 12, 2021)
- Warrant to Purchase Stock, dated December 8, 2020, issued by the Company to Perceptive Credit Holdings II, LP (Filed With SEC on March 25, 2021)
- Rights Agreement, dated as of December 16, 2020, by and between ADMA Biologics, Inc. and Continental Stock Transfer and Trust Company, as rights agent (Filed With SEC on December 16, 2020)
- Amendment No. 2 to Credit Agreement and Guaranty, dated December 8, 2020 (Filed With SEC on December 9, 2020)
- Note, dated December 8, 2020, issued by the Company to Perceptive Credit Holdings II, LP (Filed With SEC on December 9, 2020)
- Note, dated March 20, 2020, issued by the Company to Perceptive Credit Holdings II, LP (Filed With SEC on March 20, 2020)
- Description of Capital Stock of ADMA Biologics, Inc (Filed With SEC on March 13, 2020)
- Underwriting Agreement by and among the Company and the Underwriters dated as of February 6, 2020 (Filed With SEC on February 7, 2020)
- Underwriting Agreement by and among the Company and the Underwriters dated as of May 16, 2019 (Filed With SEC on May 17, 2019)
- Amendment No. 1 to Credit Agreement and Guaranty, dated as of May 3, 2019, by and among the Company, ADMA Plasma Biologics, Inc., ADMA Bio Centers Georgia Inc., ADMA... (Filed With SEC on May 3, 2019)
- Warrant to Purchase Stock, dated May 3, 2019, issued by the Company to Perceptive Credit Holdings II, LP (Filed With SEC on May 3, 2019)
- Note, dated May 3, 2019, issued by the Company to Perceptive Credit Holdings II, LP (Filed With SEC on May 3, 2019)
- Credit Agreement and Guaranty, dated as of February 11, 2019, by and among the Company, ADMA Plasma Biologics, Inc., ADMA Bio Centers Georgia Inc., ADMA BioManufacturing, LLC, and... (Filed With SEC on February 12, 2019)
- Security Agreement, dated as of February 11, 2019, by and among the Company, ADMA Plasma Biologics, Inc., ADMA Bio Centers Georgia Inc., ADMA BioManufacturing, LLC, and Perceptive... (Filed With SEC on February 12, 2019)
- Warrant to Purchase Stock, dated February 11, 2019, issued by the Company to Perceptive Credit Holdings II, LP (Filed With SEC on February 12, 2019)
- Note, dated February 11, 2019, issued by the Company to Perceptive Credit Holdings II, LP (Filed With SEC on February 12, 2019)
- Fifth Amendment to Plasma Purchase Agreement, effective as of January 1, 2019, by and between ADMA Biologics, Inc. and Grifols Worldwide Operations Limited (Filed With SEC on January 2, 2019)
- Amendment to Plasma Purchase Agreement, dated as of July 19, 2018, by and between Biotest Pharmaceuticals Corporation and ADMA BioManufacturing, LLC (Filed With SEC on August 10, 2018)
- Share Transfer, Amendment and Release Agreement, dated as of May 14, 2018, by and among Biotest Pharmaceuticals Corporation, Biotest AG, The Biotest Divestiture Trust, Biotest US... (Filed With SEC on August 10, 2018)
- Assignment and Assumption Agreement (ADMA Loan), dated as of July 20, 2018, by and among Biotest AG, Biotest Pharmaceuticals Corporation, ADMA BioManufacturing, LLC and ADMA... (Filed With SEC on July 24, 2018)
- Underwriting Agreement by and among the Company and the Underwriters dated as of June 8, 2018 (Filed With SEC on June 8, 2018)
- Underwriting Agreement, dated as of November 8, 2017, by and between the Company and Raymond James & Associates, Inc., as representatives of the several underwriters (Filed With SEC on November 9, 2017)
- Form of Underwriting Agreement (Filed With SEC on November 3, 2017)
- Pledge Agreement, dated as of October 10, 2017, by and between the Company and Wilmington Trust, National Association (Filed With SEC on October 11, 2017)
- Intellectual Property Security Agreement, dated as of October 10, 2017, by and among the Company, ADMA Plasma Biologics, Inc., ADMA Bio Centers Georgia Inc., ADMA... (Filed With SEC on October 11, 2017)
- Security Agreement, dated as of October 10, 2017, by and among the Company, ADMA Plasma Biologics, Inc., ADMA Bio Centers Georgia Inc., ADMA BioManufacturing, LLC and Wilmington... (Filed With SEC on October 11, 2017)
- Credit Agreement, dated as of October 10, 2017, by and among the Company, ADMA Plasma Biologics, Inc., ADMA Bio Centers Georgia Inc., ADMA BioManufacturing, LLC, Marathon... (Filed With SEC on October 11, 2017)
- Warrant to Purchase Stock, dated October 10, 2017, issued by the Company to Marathon Healthcare Finance Fund, L.P (Filed With SEC on October 11, 2017)
- Tranche One Term Note, dated October 10, 2017, issued by the Company to Marathon Healthcare Finance Fund, L.P (Filed With SEC on October 11, 2017)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on June 12, 2017)
- SUBORDINATED LOAN AGREEMENT (Filed With SEC on June 12, 2017)
